Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
43,318
Sort by:
2022-2026 World Immunodiagnostic Analyzers and Reagents in 90 Countries—Competitive Shares and SWOT Analysis, Volume and Sales Segment Forecasts in 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special Chemistry Tests-Latest Technologies and Instrumentation Pipeline, Emerging Opportunities in Suppliers
US$ 38,500.00
This new 90-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test. The report is available by section, and can be customized to spe...
January 2022
Global Neurorehabilitation Market Size study, by Type (Neuro-Robotic Devices, Non-Invasive Stimulators, and Brain-Computer Interfaces), by Application (Brain Stroke, Parkinson's Disease, Multiple Sclerosis, Spinal Cord Injury, Traumatic Brain Injury, Cerebral Palsy, and Others), by and End-User (Rehabilitation Centers, Hospitals, and Clinics) and Regional Forecasts 2021-2027
US$ 4,950.00
Global Neurorehabilitation Market is valued at approximately USD 1097.69 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 8.3 % over the forecast period 2021-2027. Ne...
January 2022
200 pages
Global Rat and Mouse Model Market Size study, by Type (Knockout, Knock-in, Outbred, Inbred, Others), By Technology (Nuclear transferase, Microinjection, Embryonic stem cells, CRISPR/Cas9, Others) By Service (Cryopreservation, Breeding, Rederivation, Genetic testing, Quarantine depending, Others), By Application (Cardiovascular diseases, Genetic diseases, Cancer, Infectious diseases, Transplantation, Toxicology studies, Others), By End-use (Pharmaceutical companies, Academic and research facilities, Biotechnology companies, Contract research & manufacturing organizations) and Regional Forecasts 2021-2027
US$ 4,950.00
Global Rat and Mouse Model Market is valued at approximately USD 1.9 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 5.5 % over the forecast period 2021-2027. Rat an...
January 2022
200 pages
Global Sacroiliac Joint Fusion Market Size study, By Indication (Degenerative Sacrolitiis, Sacral Disruption, Trauma), By Surgery (MIS, Open), By Product (Implants, Accessories), By End User (Hospitals, Ambulatory Surgical Centres, Others (Specialty Centers, Research & Academic Institutes)) and Regional Forecasts 2021-2027
US$ 4,950.00
Global Sacroiliac Joint Fusion Market is valued at approximately USD 187.5 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 17.5 % over the forecast period 2021-2027....
January 2022
200 pages
2022-2026 Asia-Pacific Clinical Chemistry and Immunodiagnostic Analyzers and Reagents in 18 Countries-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 14,500.00
This new 18-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is available by section, and can be customized to specific in...
January 2022